Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.

PURPOSE: We compared the in vitro susceptibility of gram-positive bacteria to ciprofloxacin and ofloxacin using human corneal susceptibility levels. METHODS: The concentrations of ciprofloxacin and ofloxacin that can be attained in 99% of human corneas (Cornea99) after topical administration were calculated statistically from reported data. The minimal inhibitory concentrations (MICs) were determined for 95 corneal isolates of gram-positive bacteria (51 Staphylococcus aureus, 16 Streptococcus pneumoniae, 16 Streptococcus viridans group, and 12 coagulase-negative staphylococci). Susceptibility was interpreted by comparing the MICs with the respective Cornea99 for each antibiotic. Time-kill studies of representative gram-positive bacteria were tested using the Cornea99 and the maximal corneal concentrations reported for ciprofloxacin and ofloxacin. RESULTS: The Cornea99 of ciprofloxacin and ofloxacin were calculated to be 3.57 microg/ml (n = 22) and 2.22 microg/ml (n = 20), respectively. The reported mean corneal concentrations of ciprofloxacin (6.90 +/- 6.20 microg/ml) and ofloxacin (5.71 +/- 6.15 microg/ml) were comparable (p = 0.54). All gram-positive bacteria were equally susceptible to ciprofloxacin and ofloxacin (p = 0.54) based on the Cornea99. The time-kill studies determined that 8-24 h were required for both ciprofloxacin and ofloxacin to reach bactericidal levels. CONCLUSION: Ciprofloxacin and ofloxacin demonstrated comparable penetration into the cornea and provided equivalent in vitro efficacy against representative gram-positive bacteria. Time-kill studies indicated that 8-24 h of continual corneal concentrations of ciprofloxacin and ofloxacin were necessary in this study to reduce susceptible gram-positive bacteria by 99.9%.